Slow-wave sleep and daytime functioning in chronic fatigue syndrome: effects of sodium oxybate
Phase of Trial: Phase IV
Latest Information Update: 28 Jan 2016
At a glance
- Drugs Sodium oxybate (Primary)
- Indications Chronic fatigue syndrome
- Focus Therapeutic Use
- Acronyms SAFFE
- 26 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jul 2015 Accrual to date is 241 % according to United Kingdom Clinical Research Network record.
- 05 May 2015 Planned End Date changed from 30 Apr 2015 to 31 Aug 2015 as reported by United Kingdom Clinical Research Network record.